Page last updated: 2024-09-03

thrombin receptor peptide sfllrnp and Disease Exacerbation

thrombin receptor peptide sfllrnp has been researched along with Disease Exacerbation in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bachoo, P; Brittenden, J; Ford, I; Greaves, M; Mckay, I; Rajagopalan, S1

Other Studies

1 other study(ies) available for thrombin receptor peptide sfllrnp and Disease Exacerbation

ArticleYear
Platelet activation increases with the severity of peripheral arterial disease: implications for clinical management.
    Journal of vascular surgery, 2007, Volume: 46, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Arachidonic Acid; Blood Platelets; Blood Pressure; Disease Progression; Female; Fibrinogen; Flow Cytometry; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intermittent Claudication; Male; Middle Aged; P-Selectin; Peptide Fragments; Platelet Activation; Prognosis; Receptors, Cell Surface; Severity of Illness Index

2007